China · Delayed Price · Currency is CNY Mingchen Health Statistics
Total Valuation
Mingchen Health has a market cap or net worth of CNY 5.25 billion. The enterprise value is 5.01 billion.
| Market Cap | 5.25B |
| Enterprise Value | 5.01B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 9, 2026 |
Share Statistics
Mingchen Health has 263.89 million shares outstanding. The number of shares has decreased by -0.26% in one year.
| Current Share Class | 263.89M |
| Shares Outstanding | 263.89M |
| Shares Change (YoY) | -0.26% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 42.01% |
| Owned by Institutions (%) | 4.60% |
| Float | 153.03M |
Valuation Ratios
The trailing PE ratio is 214.30.
| PE Ratio | 214.30 |
| Forward PE | n/a |
| PS Ratio | 3.35 |
| PB Ratio | 6.45 |
| P/TBV Ratio | 11.48 |
| P/FCF Ratio | 79.03 |
| P/OCF Ratio | 34.01 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 202.41 |
| EV / Sales | 3.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 75.41 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.73 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.64 |
| Interest Coverage | -12.26 |
Financial Efficiency
Return on equity (ROE) is 2.82% and return on invested capital (ROIC) is -2.83%.
| Return on Equity (ROE) | 2.82% |
| Return on Assets (ROA) | -1.57% |
| Return on Invested Capital (ROIC) | -2.83% |
| Return on Capital Employed (ROCE) | -3.51% |
| Weighted Average Cost of Capital (WACC) | 7.15% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 18,978 |
| Employee Count | 1,305 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 9.25 |
Taxes
In the past 12 months, Mingchen Health has paid 19.99 million in taxes.
| Income Tax | 19.99M |
| Effective Tax Rate | 46.17% |
Stock Price Statistics
The stock price has increased by +18.87% in the last 52 weeks. The beta is 0.55, so Mingchen Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +18.87% |
| 50-Day Moving Average | 22.30 |
| 200-Day Moving Average | 21.09 |
| Relative Strength Index (RSI) | 35.31 |
| Average Volume (20 Days) | 5,737,396 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mingchen Health had revenue of CNY 1.57 billion and earned 24.77 million in profits. Earnings per share was 0.09.
| Revenue | 1.57B |
| Gross Profit | 856.77M |
| Operating Income | -30.09M |
| Pretax Income | 43.30M |
| Net Income | 24.77M |
| EBITDA | -24.12M |
| EBIT | -30.09M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 348.60 million in cash and 109.12 million in debt, with a net cash position of 239.48 million or 0.91 per share.
| Cash & Cash Equivalents | 348.60M |
| Total Debt | 109.12M |
| Net Cash | 239.48M |
| Net Cash Per Share | 0.91 |
| Equity (Book Value) | 815.09M |
| Book Value Per Share | 3.09 |
| Working Capital | 307.29M |
Cash Flow
In the last 12 months, operating cash flow was 154.50 million and capital expenditures -88.02 million, giving a free cash flow of 66.48 million.
| Operating Cash Flow | 154.50M |
| Capital Expenditures | -88.02M |
| Depreciation & Amortization | 5.97M |
| Net Borrowing | 64.87M |
| Free Cash Flow | 66.48M |
| FCF Per Share | 0.25 |
Margins
Gross margin is 54.55%, with operating and profit margins of -1.92% and 1.58%.
| Gross Margin | 54.55% |
| Operating Margin | -1.92% |
| Pretax Margin | 2.76% |
| Profit Margin | 1.58% |
| EBITDA Margin | -1.54% |
| EBIT Margin | -1.92% |
| FCF Margin | 4.23% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.24%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.08% |
| Buyback Yield | 0.26% |
| Shareholder Yield | 0.50% |
| Earnings Yield | 0.47% |
| FCF Yield | 1.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 31, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | May 31, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Mingchen Health has an Altman Z-Score of 8.42 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.42 |
| Piotroski F-Score | 5 |